A Controlled Comparison of Human and AI-Assisted Automated Revision of Delphi Statements on RNA-Based Medicines: Parallel, 2-Arm Study - Summary - MDSpire

A Controlled Comparison of Human and AI-Assisted Automated Revision of Delphi Statements on RNA-Based Medicines: Parallel, 2-Arm Study

  • By

  • Enrico Nello

  • Fabio Tedone

  • Elena Caproni

  • Davide Cafiero

  • Sara Manellari

  • Paolo Rocco

  • July 13, 2026

Share

Objective:

To compare consensus outcomes between manual revisions and AI-assisted revisions of subthreshold statements using retrieval-augmented generation (RAG) and multi-agent modules.

Approach:
  • Delphi Method: Utilized a structured technique for eliciting expert judgment and achieving consensus in the context of RNA-based therapeutics.
  • AI-Assisted Pipeline: Implemented an AI-assisted Delphi pipeline to mirror human reviewer workflows in the post-round 1 phase.
Key Findings:
  • AI assistance is expected to rescue more statements by providing comprehensive evidence summaries and citation-anchored revisions.
  • Final consensus rates are anticipated to be similar to those achieved by human reviewers.
Interpretation:

Explorations of AI-facilitated Delphi exercises indicate potential for process acceleration while underscoring the importance of human oversight.

Limitations:
  • Delphi rounds are time-consuming, often taking 2 to 6 months.
  • Panelist engagement tends to decline with each round, complicating the formation of consensus.
Conclusion:

The study aims to evaluate the effectiveness of AI in enhancing the Delphi process for RNA-based therapeutics.

Sources:

Original Source(s)

Related Content